Heyman Richard A. sold ORIC
October 1, 2026 · Form 4 insider transaction
Heyman Richard A. sold 3,200 shares of ORIC Pharmaceuticals, Inc. at $12.91 per share, a transaction worth $41.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Footnotes
The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and RAHD Capital, LLC.; This transaction was executed in multiple trades at prices ranging from $12.57 to $13.39. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.; The shares are held of record by RAHD Capital, LLC, and the Reporting Person has voting and investment power with respect to such shares.